ArticleJournal of medical virology2025

Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain.

José Ramón Azanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.